US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist
  • 5.490
  • +0.260+4.97%
Close Apr 26 16:00 ET
  • 5.490
  • 0.0000.00%
Post 16:20 ET
233.69MMarket Cap-2346P/E (TTM)

Foghorn Therapeutics Key Stats

Foghorn Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

5.77M

+37.88%
EPS(YoY)

-0.57

+17.39%

Strong Buy

Apr 10, 2024

Foghorn Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 7.453M--
--2024/Q1-- / 7.352M--
--2023/Q45.769M / 5.776M--
--2023/Q317.478M / 5.651M--
--2023/Q25.599M / 6.263M--
--2023/Q15.309M / 5.038M--
--2022/Q44.184M / 10.598M--
--2022/Q36.634M / 9.583M--
--2022/Q24.490M / 8.688M--
--2022/Q13.920M / 11.267M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 7.453M--
--2024/Q1-- / 7.352M--
--2023/Q45.769M / 5.776M--
--2023/Q317.478M / 5.651M--
--2023/Q25.599M / 6.263M--
--2023/Q15.309M / 5.038M--
--2022/Q44.184M / 10.598M--
--2022/Q36.634M / 9.583M--
--2022/Q24.490M / 8.688M--
--2022/Q13.920M / 11.267M--

Unlock Free Earnings Estimates

Foghorn Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 10, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg